Recommendations of the global initiative on chronic obstructive pulmonary disease-GOLD 2020 and COVID-19
The article discusses the main provisions set out in the recommendations of GOLD 2020. The correct interpretation of the concept of COPD, the use of common diagnostic criteria, and the standardization of epidemiological and economic research are necessary conditions for assessing the true damage caused by this disease. According to the GOLD 2020 report, chronic obstructive pulmonary disease (COPD) it is defined as a disease characterized by persistent restriction of air flow, which is usually progressive and is the result of a chronic inflammatory response of the respiratory tract and lung tissue to the effects of inhaled damaging particles or gases. New approaches and algorithms for managing patients with chronic obstructive pulmonary disease are described. Each pharmacological treatment regimen should be individual and should be guided by the severity of symptoms, risk of exacerbations, side effects, comorbidities, availability and cost of the drug, as well as the patient's response, preference, and ability to use various devices to deliver the drug. Inhaler technology should be regularly evaluated. Research data shows that flu vaccination reduces the incidence of lower respiratory tract infections, and pneumococcal vaccination reduces the risk of lower respiratory tract infection. Pulmonary rehabilitation improves symptoms, quality of life, and physical and emotional participation in daily activities.